Novel Measure of Social Deficits in Children (OATS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02035176 |
Recruitment Status :
Completed
First Posted : January 14, 2014
Last Update Posted : August 28, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Autism Spectrum Disorders (ASD) feature impairments in social interaction and communication. Drug and behavioral treatments for ASD are undergoing rapid development, yet our diagnostic tools are not suitable for efficacy assessment. The Autism-Diagnosis Observational Schedule (ADOS) is a clinical interview with the child and the gold standard for diagnosis. However, this test is subjective, course grained and costly, precluding repeated tests of the same child to assess treatment efficacy and large-scale control assessments of typically developing (TD) children. For these reasons, the ADOS can impede imaging and genetic research.
In light of these concerns, the Oregon Animation Test for Social Reciprocity (OATS) will be developed to evaluate distinct autistic behavioral phenotypes, including joint attention, empathy, imitation, and lack of narrative coherence. The main idea of OATS is that animated characters and social scenarios are presented on a computer screen while the responses of the child are recorded by video camera, microphone, and eye-tracking equipment. Animations are used to test each behavioral phenotype of autism. The long-term vision for OATS is to evaluate behavioral and physiological responses of autistic children, including heart rate variability, pupil dilation, and EEG. Our first objective is to use existing animations to build an OATS "Prototype" that discriminates autistic from normal children (Aim 1). From these results, and use of a defined library of still frame posed images, we will design our own animation platform to assess differences between autistic and normal children (Aim 2).
Condition or disease |
---|
Autism Spectrum Disorders ADHD |
Study Type : | Observational |
Actual Enrollment : | 92 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Oregon Animation Test for Social Reciprocity (OATS) |
Study Start Date : | February 2014 |
Actual Primary Completion Date : | December 2018 |
Actual Study Completion Date : | December 2018 |

Group/Cohort |
---|
Autistic children ages 6-11
Autistic children ages 6-11
|
ADHD children ages 6-11
ADHD children ages 6-11
|
Typical children ages 6-11
Typical children ages 6-11
|
- Eye gaze in response to animated social situations [ Time Frame: 60 minutes ]
- Facial expressions in response to animated social situations [ Time Frame: 60 minutes ]A child is shown an animation and facial expressions are coded for various emotions.
- Ability to recount a story shown via animation [ Time Frame: 10 minutes ]A child is shown an animation and is asked to recount the story.
- Ability to imitate an action shown via animation [ Time Frame: 10 minutes ]A child is shown an animation and is asked to imitate a character's action .

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 6 Years to 11 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- 6-11 years of age with autism,
- ADHD, or typical
Exclusion Criteria:
- IQ below 70.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02035176
United States, Oregon | |
OHSU | |
Portland, Oregon, United States, 97239 | |
Oregon Health and Science University | |
Portland, Oregon, United States, 97239 |
Principal Investigator: | Garet P Lahvis, PhD | Oregon Health and Science University |
Responsible Party: | Garet Lahvis, Assistant Professor, Oregon Health and Science University |
ClinicalTrials.gov Identifier: | NCT02035176 |
Other Study ID Numbers: |
eIRB 9747 |
First Posted: | January 14, 2014 Key Record Dates |
Last Update Posted: | August 28, 2019 |
Last Verified: | August 2019 |
autism ADHD attention deficit hyperactivity disorder behavioral assessment behavior |
Autism Spectrum Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders |